BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9010119)

  • 1. Patients excluded from an antidepressant efficacy trial.
    Partonen T; Sihvo S; Lönnqvist JK
    J Clin Psychiatry; 1996 Dec; 57(12):572-5. PubMed ID: 9010119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalizability of antidepressant efficacy trials: differences between depressed psychiatric outpatients who would or would not qualify for an efficacy trial.
    Zimmerman M; Chelminski I; Posternak MA
    Am J Psychiatry; 2005 Jul; 162(7):1370-2. PubMed ID: 15994721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current comorbidity of psychiatric disorders among DSM-IV major depressive disorder patients in psychiatric care in the Vantaa Depression Study.
    Melartin TK; Rytsälä HJ; Leskelä US; Lestelä-Mielonen PS; Sokero TP; Isometsä ET
    J Clin Psychiatry; 2002 Feb; 63(2):126-34. PubMed ID: 11874213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?
    Zimmerman M; Mattia JI; Posternak MA
    Am J Psychiatry; 2002 Mar; 159(3):469-73. PubMed ID: 11870014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence of psychiatric disorders in French general practice using the patient health questionnaire: comparison with GP case-recognition and psychotropic medication prescription].
    Norton J; de Roquefeuil G; David M; Boulenger JP; Ritchie K; Mann A
    Encephale; 2009 Dec; 35(6):560-9. PubMed ID: 20004287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A reevaluation of the exclusion criteria used in antidepressant efficacy trials.
    Posternak MA; Zimmerman M; Keitner GI; Miller IW
    Am J Psychiatry; 2002 Feb; 159(2):191-200. PubMed ID: 11823258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis.
    Torrens M; Fonseca F; Mateu G; Farré M
    Drug Alcohol Depend; 2005 Apr; 78(1):1-22. PubMed ID: 15769553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
    Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
    J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An illustration of how a self-report diagnostic screening scale could improve the internal validity of antidepressant efficacy trials.
    Zimmerman M; Chelminski I; Posternak M
    J Affect Disord; 2004 May; 80(1):79-85. PubMed ID: 15094261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major depression and comorbid substance use disorders.
    Davis L; Uezato A; Newell JM; Frazier E
    Curr Opin Psychiatry; 2008 Jan; 21(1):14-8. PubMed ID: 18281835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How many subjects with major depressive disorder meet eligibility requirements of an antidepressant efficacy trial?
    Keitner GI; Posternak MA; Ryan CE
    J Clin Psychiatry; 2003 Sep; 64(9):1091-3. PubMed ID: 14628985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of social support at work and in private life with mental health and antidepressant use: the Health 2000 Study.
    Sinokki M; Hinkka K; Ahola K; Koskinen S; Kivimäki M; Honkonen T; Puukka P; Klaukka T; Lönnqvist J; Virtanen M
    J Affect Disord; 2009 May; 115(1-2):36-45. PubMed ID: 18722019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mental disorders and comorbidity in attempted suicide.
    Suominen K; Henriksson M; Suokas J; Isometsä E; Ostamo A; Lönnqvist J
    Acta Psychiatr Scand; 1996 Oct; 94(4):234-40. PubMed ID: 8911558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between depression severity entry criteria and antidepressant clinical trial outcomes.
    Khan A; Schwartz K; Kolts RL; Ridgway D; Lineberry C
    Biol Psychiatry; 2007 Jul; 62(1):65-71. PubMed ID: 17141744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual diagnosis in Spain.
    Gual A
    Drug Alcohol Rev; 2007 Jan; 26(1):65-71. PubMed ID: 17364838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbid substance and mental disorders among rural Americans: results from the National Comorbidity Survey.
    Simmons LA; Havens JR
    J Affect Disord; 2007 Apr; 99(1-3):265-71. PubMed ID: 16978706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood sexual abuse and psychiatric disorders in middle-aged and older adults: evidence from the 2007 Adult Psychiatric Morbidity Survey.
    Chou KL
    J Clin Psychiatry; 2012 Nov; 73(11):e1365-71. PubMed ID: 23218165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials.
    Iovieno N; Tedeschini E; Bentley KH; Evins AE; Papakostas GI
    J Clin Psychiatry; 2011 Aug; 72(8):1144-51. PubMed ID: 21536001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recruitment of depressive patients for a controlled clinical trial in a psychiatric practice.
    Haberfellner EM
    Pharmacopsychiatry; 2000 Jul; 33(4):142-4. PubMed ID: 10958263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural history and heterogeneity of depressive disorders: implications for rational antidepressant therapy.
    Keller MB; Hanks DL
    J Clin Psychiatry; 1994 Sep; 55 Suppl A():25-31; discussion 32-3, 98-100. PubMed ID: 7961539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.